BIOBV.HE FI Equity☆

Pricefull chart →

Mkt cap $474,300 · P/E (FY) 0.2× · 1Y −11.0% · Off 52W high −27.5% · Vol (1Y) 44.6%

Key fundamentalsfull statements →

Biohit Oyj is a biotechnology company that manufactures and sells diagnostic products and analysis systems for research institutions, healthcare, and industry worldwide. Its offerings include the GastroPanel tests and software for assessing stomach mucosa and detecting Helicobacter pylori, along with tests for vitamin B12, vitamin D, calprotectin, fecal occult blood, celiac disease, and lactose intolerance. It also provides Acetium acetaldehyde-binding products and monoclonal antibodies for research. The company was incorporated in 1988 and is headquartered in Helsinki.

Snapshot

Headline riskfull risk →

Peers

No same-industry peers in the universe for BIOBV.HE.